Tactical Advantage ETF FDAT 深 滬
已收盤 09-05 16:00:00 美东时间
21.813
+0.003
+0.01%
華盛通- 最 高21.9699
- 今 開21.9699
- 成交量 309股
- 最 低 21.79
- 昨 收 21.81
- 總市值 3337.39万
- 52周最高 21.9699
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 19.88
- 委 比 0.00%
- 總股本 153.00万
- 歷史最高 21.9699
- 量 比 0.25
- 振 幅 0.82%
- 歷史最低 17.0663
- 每 手 1
- 風險率 1.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biocardia Provides Expected Timing For Regulatory Activities For FDA And Japan PMDA Approvals Of Its CardiAMP Cell Therapy System And Helix Transendocardial Delivery Catheter
Q3 2025 Helix application for approval to FDAThe Company intends to submit for approval of the Helix Transendocardial Delivery System (Helix) to FDA as a DeNovo 510(k) application based on its safety and performance in
08-04 18:02
Lipocine's Licensing Partner, Verity Pharma, Filed A New Drug Submission For Tlando In Canada, Tlando Is The First And Only Oral Testosterone Replacement Therapy Option Approved By FDAThat Does Not Require Dose Titration
New Drug Submission filed by Lipocine's licensing partner Verity PharmaOver 700,000 total prescriptions written annually for testosterone replacement therapy (TRT) in Canada, representing large commercial opportunity
06-09 18:25
珀斯泛太平洋酒店进行里程碑式升级改造
泛太平洋酒店集团（PPHG）宣布对珀斯泛太平洋酒店进行里程碑式升级改造。这项重大投资是集团全球资产优化战略的延续。珀斯泛太平洋酒店拥有488间客房和套房，是P...
05-16 10:17
